Cardiovascular Business | Homepage

Home

CRT vs. RV pacing: Which is better for HFpEF patients?

Individuals with heart failure with preserved ejection fraction (HFpEF) and atrioventricular block might benefit more from cardiac resynchronization therapy (CRT) than conventional right ventricular (RV) pacing, according to research published in JACC: Heart Failure.

Preemie heart damage could be reversed with exercise in young adulthood

Cardiac abnormalities stemming from preterm birth can be corrected with a three-and-a-half-month exercise program in patients’ teens and twenties, according to a drug-free trial of Canadian adults.

Arsenic in drinking water linked to LV thickening, hypertrophy

Drinking water contaminated with inorganic arsenic could increase young adults’ risk of CVD by thickening the heart’s left ventricular (LV) wall and triggering hypertrophy, researchers reported in Circulation: Cardiovascular Imaging May 7.

A new gene-editing therapy has been tested on humans for the first time, resulting in a significant reduction in their low-density lipoprotein (LDL) cholesterol that could potentially last for decades. The study’s authors presented these early results at the AHA 2023 meeting.

Biotech startup aims to eradicate CAD with gene editing

A new biotech company out of Massachusetts is levering human genetics and genome editing to “turn the tide” of coronary artery disease (CAD), experimenting with CRISPR to stop CAD from ever developing in at-risk individuals.

Around the web

New imaging protocols proposed to curb rise of cardiovascular infections

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Radiology Business

What does radiology have to do with climate change?

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."

Cardiac Imaging

HeartFlow Plaque Analysis. A European Heart Journal – Cardiovascular Imaging study compared the noninvasive Plaque Analysis technology developed by HeartFlow, which uses advanced AI algorithms to evaluate coronary CT angiography (CCTA) images, with coronary plaque assessments achieved by using intravascular ultrasound (IVUS). The REVEALPLAQUE trial included data from 237 patients. Plaque Analysis showed strong correlation and high accuracy when compared with IVUS.

AI-powered coronary plaque assessments show ‘strong agreement’ with IVUS

Industry changes are making it easier for cardiologists to start families

AI-powered coronary plaque assessments show ‘strong agreement’ with IVUS

TAVR, SAVR linked to comparable long-term outcomes, new meta-analysis confirms

Mammogram findings linked to heightened risk of CVD, type 2 diabetes and hypertension

Cardiac Surgery

Cardiologist Heart Doctor Tablet Technology

TAVR, SAVR linked to comparable long-term outcomes, new meta-analysis confirms

FDA announces another new recall involving Abbott’s HeartMate 3 LVADs after 70 injuries, 2 deaths

New hypertrophic cardiomyopathy guidelines highlight importance of exercise, new drug class

FDA warns against use of troubled heart devices, citing ‘continued concerns’ after multiple recalls

Moderate aortic stenosis linked to heightened risk of death—should TAVR, surgery be considered?

Clinical

Medicare money payment physician. The CardioVascular Coalition and Society for Cardiovascular Angiography and Interventions have both issued new statements highlighting their issues with the 2024 MPFS proposed rule.

Hospital to pay $24.3M over TAVR allegations

Myval TAVR valve noninferior to similar devices from Medtronic, Edwards after 30 days

FDA clears advanced AI model for predicting heart failure risk

Cardiologists examine how residual TR after transcatheter tricuspid valve repair impacts survival

AI-powered coronary plaque assessments show ‘strong agreement’ with IVUS

Healthcare Management

Medicare money payment physician. The CardioVascular Coalition and Society for Cardiovascular Angiography and Interventions have both issued new statements highlighting their issues with the 2024 MPFS proposed rule.

Hospital to pay $24.3M over TAVR allegations

FDA clears advanced AI model for predicting heart failure risk

Industry changes are making it easier for cardiologists to start families

Cardiologists examine how residual TR after transcatheter tricuspid valve repair impacts survival

Medical device startup gains FDA clearance for new RF guidewire, raises $12.5M

Interventional Cardiology

Medicare money payment physician. The CardioVascular Coalition and Society for Cardiovascular Angiography and Interventions have both issued new statements highlighting their issues with the 2024 MPFS proposed rule.

Hospital to pay $24.3M over TAVR allegations

Myval TAVR valve noninferior to similar devices from Medtronic, Edwards after 30 days

Cardiologists examine how residual TR after transcatheter tricuspid valve repair impacts survival

Medical device startup gains FDA clearance for new RF guidewire, raises $12.5M

FDA grants breakthrough device designation to new TMVR device from 4C Medical

Patient Care

Sarah Jane Rinehart, MD, director of cardiac imaging, Charleston Area Medical Center, Charleston West Virginia, as been using the FDA-cleared RoadMap artificial intelligence algorithm from HeartFlow in studies and in clinical used since it was cleared and said it helps cardiologists in several ways. #ACC #ACC24 #ACC2024 #Heartflow #AIhealth

AI improves CT assessments, boosts care for real-world heart patients

Cardiology ranked No. 2 among all specialties with 122 FDA-cleared AI models

PaceMate names former Philips, BioTelemetry leader its new chief commercial officer

New hypertrophic cardiomyopathy guidelines highlight importance of exercise, new drug class

Dual-action thrombectomy device could give cardiologists a new tool for treating acute PE

Professional Associations

Meril Life Sciences, an India-based medical device company founded in 2006, developed the Myval TAVR valve

Myval TAVR valve noninferior to similar devices from Medtronic, Edwards after 30 days

Industry changes are making it easier for cardiologists to start families

AI-powered coronary plaque assessments show ‘strong agreement’ with IVUS

TAVR, SAVR linked to comparable long-term outcomes, new meta-analysis confirms

Mammogram findings linked to heightened risk of CVD, type 2 diabetes and hypertension

TAVR

Medicare money payment physician. The CardioVascular Coalition and Society for Cardiovascular Angiography and Interventions have both issued new statements highlighting their issues with the 2024 MPFS proposed rule.

Hospital to pay $24.3M over TAVR allegations

Myval TAVR valve noninferior to similar devices from Medtronic, Edwards after 30 days

TAVR, SAVR linked to comparable long-term outcomes, new meta-analysis confirms

Updated balloon-expandable TAVR valve from Edwards outperforming its predecessors

Moderate aortic stenosis linked to heightened risk of death—should TAVR, surgery be considered?

Design by Adaptive Theme